Lung AI vs syngo.CT CaScoring
AI Verdict
Choose Lung AI if…
Choose Lung AI if you need a portable, real-time diagnostic tool for immediate assessment of cardiac and lung conditions at the point of care. Its AI-powered detection of pleural effusion, consolidation/atelectasis, and cardiac indicators like LVEF and stroke volume make it ideal for emergency medicine, critical care, and situations where rapid, on-device analysis is crucial, even with less-than-perfect scans.
View Lung AI →Choose syngo.CT CaScoring if…
Choose syngo.CT CaScoring if your primary need is detailed, quantitative analysis of coronary artery calcifications from CT scans for cardiovascular risk assessment. This tool excels at calculating Agatston, volume, and calcium mass scores, visualizing calcified lesions, and comparing patient scores to healthy reference groups, making it suitable for comprehensive cardiology and radiology workflows focused on long-term risk stratification.
View syngo.CT CaScoring →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Lung AI | syngo.CT CaScoring |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | On-device (integrated with Exo Iris handheld ultrasound device) | Integrated with Siemens CT scanner systems; operates as a post-processing application on the multi-user syngo.via client/server platform. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Lung AIExo Lung AI is designed for ease of use, particularly for non-experts and those with limited ultrasound experience, by providing real-time feedback, guided image capture, and on-device AI processing that operates without internet. syngo.CT CaScoring, while offering automatic highlighting and user-modifiable thresholds, is a post-processing application integrated with Siemens CT systems, suggesting a more specialized user base and workflow.
Clinical Value
Lung AIExo Lung AI offers real-time, AI-powered detection of pleural effusion and consolidation/atelectasis, with studies showing significant improvement in diagnostic accuracy for clinicians, especially less experienced users. syngo.CT CaScoring provides quantification and visualization of calcified coronary lesions for cardiovascular risk assessment, which is valuable, but Exo Lung AI's ability to assist in real-time, critical decision-making at the point of care for a broader range of users gives it an edge in immediate clinical impact.
Pricing & Value
TieBoth tools require contacting the vendor for current pricing, making a direct comparison difficult. While a historical list price for syngo.CT CaScoring was found from 2018, it's not reflective of current market value. Without transparent and up-to-date pricing for either, it's impossible to definitively determine which offers better value.
Enterprise Readiness
syngo.CT CaScoringsyngo.CT CaScoring is integrated with Siemens CT scanner systems and operates on the multi-user syngo.via client/server platform, indicating a robust solution designed for existing enterprise imaging infrastructure. Exo Lung AI, while highly portable and on-device, is a newer handheld solution, and its enterprise integration capabilities beyond the individual device are less explicitly detailed in the provided information.
Innovation
Lung AIExo Lung AI demonstrates higher innovation by integrating AI directly into a high-performance, handheld ultrasound device for real-time, on-device processing without internet connectivity. This approach significantly expands access to advanced imaging and AI assistance at the point of care, particularly for non-experts. syngo.CT CaScoring, while utilizing AI for advanced quantification, is a post-processing application on established CT systems.
Support & Docs
syngo.CT CaScoringSiemens, as a large and established medical technology provider, explicitly mentions a 'Document Library (SDS, IFU, etc.)' and 'Education & Training' through 'Siemens Healthineers Academy' for syngo.CT CaScoring. While Exo provides POCUS education and training (Exo U), the breadth and depth of formal documentation and support infrastructure are not as extensively detailed as for Siemens.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Lung AI | syngo.CT CaScoring |
|---|---|---|
| Tool Name | Lung AI | syngo.CT CaScoring |
| Company | Exo | Siemens Medical Solutions USA |
| Tagline | Handheld AI Ultrasound for Smarter Cardiac and Lung Scanning. | AI-powered quantification and visualization of coronary calcifications |
| Key Features (Lung-related) | AI-powered detection of pleural effusion, AI-powered detection of consolidation/atelectasis | Not specified |
| Key Features (Cardiac-related) | Automated AI-based indicators for cardiac conditions (e.g., heart failure, hypertrophy), Pulsed-wave Doppler capabilities (on Exo Iris) | Quick quantification and accurate visualization of calcified coronary lesions, Calculation of Agatston Score, volume, and calcium mass, Assessment of plaque burden in total and per coronary artery (RCA, LM, LAD, CX), Automatic highlighting of coronary calcifications, User-modifiable threshold for score calculation (default 130 HU), Comparison of patient score to healthy reference groups (e.g., MESA study), Calculation of 'Coronary Age' |
| Specialties | Cardiology, Emergency Medicine, Pulmonology | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Lung AI and syngo.CT CaScoring.